Nuveen Fund Advisors’s Pfizer PFE Stock Holding History

Nuveen Fund Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-20,156	Closed	-$679K	–	217
2018 Q1	$679K	Sell	20,156 -23,754	-54%	-$817K	0.31%	96
2017 Q4	$1.51M	Sell	43,910 -30,174	-41%	-$1.03M	0.44%	58
2017 Q3	$2.51M	Sell	74,084 -42,407	-36%	-$1.36M	0.51%	54
2017 Q2	$3.71M	Sell	116,491 -31,208	-21%	-$984K	0.59%	47
2017 Q1	$4.79M	Sell	147,699 -35,214	-19%	-$1.11M	0.63%	32
2016 Q4	$5.64M	Sell	182,913 -48,479	-21%	-$1.48M	0.81%	21
2016 Q3	$7.44M	Sell	231,392 -9,520	-4%	-$318K	1.04%	10
2016 Q2	$8.05M	Buy	+240,912	New	+$7.69M	1.24%	3

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Fund Advisors's PFE Position: Q2 2018 in Review

Nuveen Fund Advisors sold out of Pfizer (PFE) in Q2 2018, closing a stake of 20,156 shares — an estimated $679K sold.

Nuveen Fund Advisors first reported a position in PFE in Q2 2016 and held it in 8 quarters. The position peaked at $8.05M in Q2 2016. 2,204 funds tracked by Wall St. Rank hold PFE as of Q2 2018.

Nuveen Fund Advisors reported no remaining Pfizer position as of Q2 2018 after selling out during the quarter.
Nuveen Fund Advisors sold 20,156 Pfizer shares in Q2 2018, an estimated $679K.
Nuveen Fund Advisors first reported a position in Pfizer in Q2 2016 and held it in 8 quarters.
Nuveen Fund Advisors's Pfizer position peaked at $8.05M in Q2 2016.
2,204 funds tracked by Wall St. Rank held Pfizer as of Q2 2018.

Based on Nuveen Fund Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.